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Abstract: Here, the various types of naturally synthesized metallic nanoparticles, which are essentially
composed of Ce, Ag, Au, Pt, Pd, Cu, Ni, Se, Fe, or their oxides, are presented, based on a literature
analysis. The synthesis methods used to obtain them most often involve the reduction of metallic
ions by biological materials or organisms, i.e., essentially plant extracts, yeasts, fungus, and bacteria.
The anti-tumor activity of these nanoparticles has been demonstrated on different cancer lines.
They rely on various mechanisms of action, such as heat, the release of chemotherapeutic drugs under
a pH variation, nanoparticle excitation by radiation, or apoptotic tumor cell death. Among these
natural metallic nanoparticles, one type, which consists of iron oxide nanoparticles produced by
magnetotactic bacteria called magnetosomes, has been purified to remove endotoxins and abide by
pharmacological regulations. It has been tested in vivo for anti-tumor efficacy. For that, purified and
stabilized magnetosomes were injected in intracranial mouse glioblastoma tumors and repeatedly
heated under the application of an alternating magnetic field, leading to the full disappearance of
these tumors. As a whole, the results presented in the literature form a strong basis for pursuing the
efforts towards the use of natural metallic nanoparticles for cancer treatment first pre-clinically and
then clinically.
Keywords: natural metallic nanoparticle; natural nanoparticle; bio-synthesized nanoparticle; plant
synthesized nanoparticle; bacterial nanoparticle; magnetosomes; cancer; alternating magnetic
field; magnetic hyperthermia; glioblastoma; GBM; anti-tumor activity; nanomedicine; nanoparticle;
magnetotactic bacteria
1. Introduction
Many studies have reported the potential of metallic nanoparticles (NP) of different compositions,
e.g., Pt, Pd, Au, Fe, Ag, Ni, Cu, Se, or their oxides, for cancer treatments, through various mechanisms
of action, such as the local production of heat [1], controlled drug release [2], or an enhancement of the
effect of radiation [3]. While the most straightforward definition of a NP is that of a material with at
least one dimension at the nanometer scale, it can be widened to include any compound that would
cause or be responsible for a phenomenon at this scale, e.g., an enhanced catalytic activity [4]. Although
this broader definition has a more sound scientific ground, it is rarely used, since the tools at our
disposal to directly observe or measure nano-metric phenomena, specifically dynamic ones, are still
lacking. In order for a cancer treatment to be optimal, it should on the one hand efficiently target cancer
cells and, on the other hand, be controllable on demand. This approach should maximize its efficacy
while minimizing its side effects. Using nanoparticles, it is possible to fulfill these two objectives.
Indeed, specific cancer cell targeting can be achieved through: (i) passive targeting also designated
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as EPR effect where nanoparticles passively diffuse through the angiogenic blood vessels irrigating
the tumor, (ii) active targeting by attaching a targeting ligand to the nanoparticles that specifically
recognize a cancer cell receptor, or (iii) magnetic targeting by applying a magnetic field on nanoparticles
that trigger nanoparticle diffusion towards the tumor [5]. Furthermore, in many interesting cases
described in the literature, nanoparticles can be activated on demand, for example by being illuminated
with a laser or by being exposed to an alternating magnetic field, X-rays, or ultrasounds [5]. Most of
them report results that are obtained with nanoparticles that were chemically synthesized using
methods, such as precipitation, sonication, ball milling, thermal decomposition, spray pyrolysis,
thermal hydrolysis, and sol–gel [4,5]. These chemical syntheses suffer from drawbacks, such as
the uses of toxic solvents/reagents, high temperature/pressure, or additives needing to be added
for metallic NP stabilization during the reaction of metallic NP formation. Besides, the methods of
nanoparticle chemical synthesis are not always reproducible, i.e., the same nanoparticle parameters,
such as nanoparticle sizes, distributions in sizes, geometry, shapes, cannot always be obtained from
one batch to another. Although this is rarely described in the literature, such variations can be due
to the use of containers made of different materials or with different volumes or to local changes in
temperatures or pressures at the nanometer scale that are not observable with standard sensors [6].
By naturally synthesizing metallic NP, toxic products can be avoided and the environment can be
respected since biological substances that are necessary for such synthesis are either used in limited
quantity, e.g., for plants, or can be grown/amplified almost indefinitely without requiring a lot of
natural resources, as it is the case for bacteria. In addition, living organisms, such as magnetotactic
bacteria, may minimize variations in NP properties by using their own metabolism to produce NP,
which might, to some extent, prevent the impact of environmental changes on NP properties [7].
After a presentation of the different types of natural metallic NP that have been described
in the literature, I summarize the various ways in which they can be obtained, which depend on
the type of biological material used for the synthesis, i.e., essentially fungus, yeast, plant extracts,
and bacteria. The mechanisms of action that were associated with metallic NP anti-tumor activity were
reported to involve, among others, apoptosis and anti-angiogenesis and depend on NP composition,
the association (or not) of metallic NP with a chemotherapeutic drug, or the activation of NP through
the application of radiation. Whereas anti-tumor activity of the majority of natural metallic NP was
assessed in vitro, in vivo anti-tumor efficacy was also demonstrated with magnetosomes, which are
iron oxide nanoparticles that are synthesized by magnetotactic bacteria. Indeed, it was shown that the
administration of magnetosomes inside intracranial GBM mouse tumors followed by the repetitive
heating of these tumors under alternating magnetic field application leads to full tumor disappearance.
2. Advantages of Natural Chemical Synthesis of Metallic Nanoparticles
Naturally synthetizing metallic nanoparticles (NP) presents a number of advantages, such as:
(i) the possibility to mass produce metallic NP without using toxic compounds [6], (ii) the ease
with which the raw material can be found, (iii) a secured working environment due to the use of
non-toxic biological materials, (iv) a reasonable cost in most cases, (v) a respect of the environment,
(vi) the existence of a large number of biological compounds that can be chosen for the synthesis,
such as plant metabolites acidic compounds, aldehydes, alkaloids, amino acids, alkaloids, aromatic
amines, flavonoids phenolic compounds, ketones, phenols, phyto-proteins, polysaccharides, proteins,
saponins, steroids, sugar compounds, tannins, terpenoids, vitamins, fungus, yeast, bacteria, virus,
and bio-polymer [8], (vii) biological entities, which can have multiple functions at the same time,
often combining a reducing capacity of metallic ions with either a stabilizing role, e.g., for starch, dextran,
alginate, cellulose, chitin, yeast/fungus extracts, or a chemotherapeutic effect, e.g., for curcumin [9–11],
(viii) the possibility to reach optimized NP properties, such as a high NP production yield, or a desired
NP size/shape, by adjusting various synthesis parameters, such as the type of biological and metallic
precursor materials used, the ratio between the quantities of precursor and biological material, the pH,
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temperature, or time of the reduction reaction [12], and, finally, (ix) the possibility to genetically modify
certain living organisms to optimize metallic ion bio-mineralization by these organisms [11].
3. The Different Types of Bio-Synthesized Metallic Nanoparticles
The various metallic bio-synthesized NP were shown to be of various compositions. First, CeO2
NP, which have excellent catalytic properties due to their large bang gap and exciton binding energies,
can be obtained by mixing Ce precursors, such as cerium acetate, cerium nitrate, and cerium chloride,
with plant extracts acting as reducing agents, leading to CeO2 crystalline spherical NP of 4–19 nm [13].
Second, Ag NP, which have been shown to display anti-tumor and anti-bacterial activities, can be
produced through the reaction between silver nitrate salt (AgNO3) and different reducing agents,
such as plant extracts, i.e., originating from proteins, carbohydrates, flavonoids, phenols, vitamins,
capsaicinoids, curcumin, basil, Pelargonium graveolens, Podophyllum hexandrum, Cinnamomum
camphora, bark, callus, flower, fruit, stem, seed, peel, leaves, petals, and rhizome, to yield stable
crystalline spherical/triangular Ag NP of a wide range of different sizes of 5–80 nm, depending on
the synthesis method [9,14,15]. Third, Au NP, which have been shown to induce apoptotic cancer
cell death, can be produced by mixing chloroauric acid (HAuCl4) with plants, plant extracts, or leafs,
such as Brassica Junceae, Medicago Sativa, Picea Mariana, curcumin, quercetin, lemon grass, Neem,
and Pear fruit, typically resulting in triangular, pentagonal, hexagonal, and spherical Au NP of 2 to
300 nm [9,10,14]. Fourth, Cu/CuO NP, which can be obtained cost effectively while using plant extract
reducing agents, such as L-ascorbic acids, amino acids, reducing sugars, and phenolic compounds,
typically consist of spherical Cu/CuO NP of 3 to 250 nm [15]. Fifth, Se NP can be produced through the
reduction of a selenium precursor, such as SeO3
2− by leaf extracts of Capsicum Annuum, fruit extracts
of Vitis Vinifera, polysaccharides extracted from Undaria Pinnatifida, typically resulting in spherical
Se NP of 3–18 nm [16–18]. Sixth, Ni/NiO NP can be synthesized through the reduction of Nickel ion
sources, such as Ni(NO3)2 or NiCl2, by: (i) different parts of plants, such as leaves, petals, and roots,
e.g., of Medicago, Ocimum sanctum, Hibiscus rosa-sinensis, and rambutan peel waste, (ii) products,
such as C2H4, resulting from the pyrolysis of petals, (iii) fungus, such as Aspergillus aculeatus, or (iv)
Nickel resistant bacteria MRS-1, typically yielding well-dispersed stable face-centered cubic Ni NP of
1–200 nm [19]. Seventh, Pd NP, which can be obtained through the reduction at room temperatures of
a Pd source, such as PdCl2 by plant or leaf extracts, e.g., of cinnamomum camphora, coffee, tea extract,
or plant polymer gum ghatti, typically result in cubic faced-centered crystallized NP of 2–60 nm [9].
Eight, the formation of Pt NP of 2–23 nm can result from the reaction at 95 ◦C between a Pt solution
such as chloroplatinic acid hexaydrate (H2PtCl6·6H2O) and various plant extracts, e.g., of Diopyros
kaki, Cacumen platycladi extract, and Terminalia chebula [9]. Nineth, TiO2 NP can be obtained
through the reduction of Titanium dioxide hydrate by some plant extracts [15]. Tenth, hexagonal,
spherical, rod, and crystalline ZnO NP of 9–180 nm can be produced through the reduction of different
zinc compounds, e.g., zinc acetate, zinc nitrate, and zinc sulfate, by: (i) various plants, stem, leaf,
flower, fruit, trees, herbs, ornamentals, and seaweeds, Aloe vera, palm pollen, and dried leaves, which
accumulate zinc [15]. Eleventh, the synthesis of different types of iron-based NP was also reported,
which could result from the reduction of iron sources by plant extracts (Amaranthus spinosus leaf
aqueous extracts) or various bacteria intracellularly or extracellularly [15].
4. The Various Bio-Synthesis Methods of Metallic Nanoparticles
First, NP synthesis can be carried out using whole plants or plant extracts, originating, for example,
from stem, leaf, flower, fruit, root, latex, seed, and seed coat, which are mixed or brought into contact
with a solution of metal salt during various lengths of time at various temperatures and pH under
agitation (or not). This leads to the reduction of metallic ions into NP. Furthermore, certain plants,
called hyper-accumulator, which are accumulating high metal concentrations, can be used for improving
this fabrication process [13]. Although plant extracts appear to be very appealing for synthesizing
metallic NP, there was not any attempt to the author knowledge to purify these extracts in order to make
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them compatible with pharmaceutical regulation and, hence, be able to use them in a pharmaceutical
production process.
Second, the production of metallic NP can also be achieved by fungus or yeasts, especially
those that absorb large quantities of metals from their environment [20], often involving extracellular
proteins/enzymes and/or mechanisms of bio-precipitation, chelation, or intra-cellular NP crystallization.
Examples of yeast and fungus that can form NP include a marine strain of ascomycetous yeast
Yarrowia Lipolytica that produce Ag NP [21], fungi Cladosporium Oxysporum that convert Au ions
into Au NP [22], and Candida Utilis that bio-synthesize Ag NP [23].
Third, metallic NP can be produced by marine algae, which comprise biological compounds and
secondary metabolites that can synthesize metallic NP [24] Examples of such algae include Codium
capitatum for the Ag NP biosynthesis [24], extracts of Chlorella vulgaris for Pd NP production [21],
extracts of Turbinaria Conoides for Au NP obtention [24], and Sargassum Muticum extracts to yield
ZnO NP [24].
Fourth, metallic NP can be formed by viruses using proteins of their capsids that, can under
certain circumstances, interact with metallic ions and reduce them into NP [20], e.g., enabling Pd NP
synthesis [25] or Zn/Cd sulfide NP synthesis by M13 bacteriophage [26].
Fifth, it is also possible to use certain nutrients or natural materials, such as egg white proteins and
honey for metallic NP production, e.g., CeO2 NP [13]. Mechanisms of such synthesis were reported
to rely on interactions between Ce3+ and oppositely charged egg white proteins or hydroxyl/amine
groups of carbohydrates, enzymes and vitamins, of honey matrix [13].
Sixth, it was also reported that metallic NP could be produced by gram-positive or gram negative
bacteria, intracellularly or extracellularly. The most commonly reported metallic NP of this type are
composed of iron oxide, possibly due to the high level of bio-compatibility that is associated with
such composition, multiple potential uses of iron by bacteria, and ubiquitous iron presence in the
environment [27]. Such bacterial synthesis involves certain proteins/enzymes, such as dodecameric
(Dps), ferritin, and encapsulin, which participate in oxydo/reduction reactions, leading to NP formation.
Magnetotactic bacteria, such as MSR-1 and AMB-1, are responsible for the intracellular fabrication
of membrane bounded Fe3O4 NP, called magnetosomes [28], while iron-reducing bacteria, such as
Geobacter Metallireducens or Actinobacter sp., produce extracellularly maghemite NP [27]. Both types
of intracellular/extracellular synthesis occur in the presence of an iron source under different conditions
of oxygenation. Other types of metallic NP can result from the reduction of various metallic ions
different from iron, i.e.,: (i) selenite can be transformed into Se NP by Actinomycetes, Thauera selenatis,
or E. coli [29–35], and (ii) Au chloride can be nano-formulated by the external cell membrane of
Bacillus Subtilis [36]. In some cases, such synthesis involves specific enzymes, which favor electron
transfers and oxydo-reduction reactions, such as NADH reductase, resulting for Pseudomonas
aeruginosa bacterium in the intracellular production of Pd, Ag, Rh, Ni, Fe, Co, Pt, and Li NP [37],
and leading for bacterium Streptomyces sp. LK-3 to the extracellular formation of Ag NP [38].
Concerning metallic NP synthesis outside of bacteria, it could be achieved with the help of extracellular
polymeric substances (EPS), e.g., those of Alteromonas Macleodii that resulted in the fabrication of Ag
NP [39]. Other types of metallic NP, such as those made of Te and Se, were also synthesized by certain
bacterial species, such as Ochrobactrum sp. [40]. Metallic NP synthesis by bacteria does not only
depend on the types of bacteria involved, but also on environmental factors, such as temperature, e.g.,
the synthesis of Ag NP by Morganella Psychrotolerans yielded triangular and hexagonal nanoplates at
20 ◦C and spherical nanoparticles at 25 ◦C.
Finally, certain bio-polymers or bio-molecules possessing hydroxyl groups, such as agarose,
glucose, sucrose, starch, and PEG, were used to synthesize metallic NP, e.g., CeO2 and Ni NP [13,19].
Table 1 summarizes the physico-chemical properties of the various natural metallic nanoparticles
(metallic composition, organic part, size, shape, crystallinity, zeta potential, and presence of surface
plasmon resonance peak, synthesis method).
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Table 1. Properties of different types of natural metallic nanoparticles, including the metallic composition, the organic part, the size, the shape, the crystallinity, the
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5. In Vitro Anti-Tumor Activities of Bio-Synthesized Metallic Nanoparticles
The anti-tumor activity of metallic NP composed of Ni/NiO2 [64,65], ZnO [66], Ag [67], Au [68–70],
iron oxide [71], and Se [35] has been demonstrated on liver, colon, breast, skin, and hepatoma cancer
cells [35,65–72], highlighting the potential of these bio-synthesized metallic NP for the treatment
of various cancers. When natural metallic NP were incubated with cancer cells, different levels of
cytotoxicity were observed, depending on NP/cancer cell type, i.e., the percentage of living cells
decreased: (i) from 80% for 87 µg/mL of ZnO NP incubated with HePG2 during 24 h to 20% for
2800 µg/mL of ZnO NP incubated with these cells [67], (ii) from 90% for 0.9 µg/mL of Ag NP
incubated with MCF-7 breast cancer cells during 24 h to 10% for 30 µg/mL of Ag NP incubated
with these cells [68]. A comparison between the efficacy of metallic NP of various compositions was
carried out for Au and Ag NP synthesized by plants Plumbago zeylanica, Commelina nudiflora,
and Cassia auriculata, which indicated that Ag was more cytotoxic than Au towards various cancer
cell lines [72]. More comparative studies deserve to be carried out in order to determine which metallic
NP composition would potentially yield the most efficient anti-tumor effect. Three cases can be
distinguished concerning the impact of NP composition on anti-tumor activity. First, the biological
material used for metallic NP synthesis is cytotoxic and it ends up at the surface or in the composition of
metallic NP, inducing a cytotoxicity towards cancer cells, which is larger than that of the free biological
material, as observed for Ni NP associated with Verbascoside [65], or Au NP combined with Cur [70,73].
Second, a cytotoxic extract of plant can be added to metallic NP after nanoparticle synthesis; this
fabrication process presented the advantage of offering the choice between different types of cytotoxic
compounds that can be attached to the metallic NP backbone. Thirdly, bio-synthesized metallic NP
may not comprise any natural cytotoxic compounds, in which case cytotoxicity might be induced by
the metallic NP backbone or by other mechanisms of tumor destruction than purely cytotoxic ones,
such as those involving the immune system. In vitro studies of tumor cell destruction have highlighted
a whole variety of different types of mechanisms of tumor cell destruction, such as anti-angiogenesis, as
observed for liver cancer cells brought into contact with ZnO NP synthesized by Sargassum muticum
extracts [67], apoptosis induced by the expression of pro-apoptotic Bax protein in MCF-7 human breast
cancer cell line in the presence of Au NP [73], pH-controlled drug release, e.g., Gingerol 6G or Cur
could be released from IONP in this manner [72], the delivery of the two chemotherapeutic drugs
doxorubicin and Quercetin associated with Au NP by infrared light illumination [74], mechanical
damage/disruption of cell membrane by CeO NP [75,76], DNA damage that is induced by Au and
Ag NP [77,78], the prevention of drug aggregation via drug conjugation to Se NP that enhances drug
bio-availability [79], and tumor cell targeting of drug-NP conjugates through the specific interactions
between drug compounds (carbohydrates) and cell receptors (lectins) [80].
6. Preparation and In Vivo Anti-Tumor Assessment of Magnetosomes
Only few bio-synthesized metallic NP had their anti-tumor efficacy examined in vivo. The reason
for that may be that despite their potential, many metallic NP formulations may not have reached a
sufficiently high level of accomplishment or be fully compatible with pharmaceutical regulation to
warrant in vivo evaluations. Even so, the presence of biological material, such as plant extracts in
the final formulation, is often perceived as an advantage due to the natural origin of such substance,
it might be difficult to obtain it reproducibly and identically from batch to batch. A detailed description
of the methods used for purifying metallic NP, as well as the exact metallic NP composition resulting
from such methods, are also often lacking. Furthermore, metallic NP characterization should go
beyond the sole estimate of nanoparticle size, which is often the only reported NP property.
As a first example, Au NP associated with Resveratrol (RES–Au NP) were administered to mice
bearing liver tumors, yielding better anti-hepatoma efficacy than for free Resveratrol, [81].
As a second example, magnetosomes, which are iron oxide nano-minerals surrounded by
biological material made of lipids/proteins [82], synthesized by magnetotactic bacteria (MTB), have been
developed methodically, in order to enable their administration to a living organism. First, the MTB
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species, which is the best suited for medical applications, was determined. MTB are ubiquitous in the
environment, belonging to a broad range of different classes, as shown in Figure 1, i.e., zetaproteobacteria,
beta-proteobacteria, Gammaproteobacteria, Deltaproteobacteria, Epsilon-proteobacteria, Nitrospirae,
OP3, and Alphaproteobacteria. However, only certain species of Alphaproteobacteria such as
Magnetospirillum gryphiswaldense MSR-1, Magnetospirillum magneticum AMB-1, Magnetovibrio
MV-1, Magnetococcus sp. MC-1, Magnetospirillum magnetotacticum MS-1, and Magnetospirillum
sp. ME-1, could be grown under controlled conditions [83]. Among these species, MSR-1 seems
particularly interesting. Indeed, it was shown that MSR-1 could be amplified with a good yield,
i.e., the production of 10 mg of magnetosomes per liter of growth medium, by using a reduced growth
medium that is devoid of chemicals of animal/cell origin, such as peptone and yeast extract, which are
often used to promote bacterial growth, and of toxic substances, such as CMR (carcinogenic, mutagenic,
reprotoxic) products and heavy metals. It yielded pure iron oxide nanoparticles, using a production
method that abides by pharmaceutical production standards [7].
 
Figure 1. A schematic diagram presenting the various categories of magnetotactic bacteria (blue
background), species of magnetotactic bacteria belonging to Alphaproteobacteria that can be amplified
in specific growth media (dark apple green background), species of magnetotactic bacteria belonging to
Alphaproteobacteria that can be amplified in specific growth media and can produce more than 10 mg
of magnetosomes per liter of growth medium (yellow green background), MSR-1 specie belonging to
Alphaproteobacteria that can be amplified in specific growth media, can produce more than 10 mg
of magnetosomes per liter of growth medium, and can be amplified in minimal growth media not
containing peptone, yeast extract, toxic CMR products, and heavy metals.
Magnetotactic bacteria being gram negative, they contain LPS at the surface of their
membrane, which should be removed for injection, notably to prevent skeptic shock. For that,
an extraction/purification method was developed, in which MTB and extracted magnetosomes were
treated with detergents (KOH or NaOH) and heat in order to remove biological material, including LPS
from the magnetosome minerals. Finally, the minerals thus obtained were coated with several synthetic
substances, such as Poly-L-lysine under sonicating conditions, in order to yield nano-formulated
magnetosome minerals coated with Poly-L-lysine (M-PLL), which were stable and non-pyrogenic [84].
Figure 2 presents a schematic diagram with the different steps of the production of M-PLL, which
include: (i) growth and amplification of MSR-1 magnetotactic bacteria starting with a pre-amplification
Int. J. Mol. Sci. 2020, 21, 4412 10 of 18
of MTB without feeding the bacteria with iron followed by growth of MTB under iron fed-batch
conditions (step 1), (ii) the extraction of magnetosomes from MTB, and (iii) the purification of
magnetosomes to remove organic materials and yield magnetosome minerals and finally coating of
magnetosome minerals with poly-L-lysine (step 3).
 
Figure 2. Schematic diagrams presenting the different steps of magnetosome production, which include:
step 1) growth/amplification of magnetotactic bacteria, this step being divided between a pre-growth
step where magnetotactic bacteria (MTB) are amplified without a source of iron and a growth step during
which MTB are grown by being fed with a fed-batch medium containing a source of iron under sustained
oxygen gas bubbling to promote magnetosome production, step 2) extraction of magnetosomes from
MTB by mixing MTB with KOH and isolating extracted magnetosomes with a magnet, step 3) a
treatment with detergents or heat to obtain magnetosome minerals and a sonication of these minerals
with a synthetic coating (Poly-L-Lysine) to yield stable coated magnetosome minerals (M-PLL).
M-PLL were administered at a concentration of 350–450 µg in iron per mm3 of tumor at the
center of GBM tumors of 1.5 mm3 grown in mouse brains to evaluate the anti-tumor efficacy of these
nanoparticles. Mice were then exposed to 27 magnetic sessions (MS), during which an alternating
magnetic field of 200 kHz and 27 mT was applied during 30 min. [84]. For a typical mouse, Figure 3
shows the rapid tumor disappearance resulting from the treatment, which is highlighted by the
decrease of tumor volume, as deduced from bioluminescence measurements and the absence of tumor
cells observed through histological analysis of treated mouse brains 75 and 125 days following the
beginning of the treatment [84]. The tumor temperature recorded during each session increased
moderately, not exceeding 43 ◦C, indicating that such treatment might be compatible with the treatment
of a human brain, which might withstand a moderate temperature increase.
Figure 4 illustrates, through a series of fours schematic diagrams, the different mechanisms that
could be involved in the anti-tumor activity, i.e.,: (i) localized heat induced at magnetosome location
that could occur inside or outside tumor cells, depending on whether (or not) magnetosomes have
internalized in tumor cells [54,85], (ii) a mechanism of tumor cell death dominated by apoptosis as
was observed during in vitro studies where magnetosomes were brought into contact with GBM cells
and then exposed to one magnetic session [53,84], (iii) anti-tumor activity due to the presence of the
magnetosomes within tumor margin, (iv) the attraction of certain immune cells, such as PNN, in the
region where magnetosomes are located, even so a direct link between the anti-tumor activity and
the presence of PNN has not yet been established [53,84]. In cases where magnetosomes are heated
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under the application of radiation, e.g. a laser or an alternating magnetic field, heat appears to be the
dominant mechanism of action since tumor disappearance is not observed in the absence of heat, and
magnetosomes are therefore classifiable as medical devices.
 
Figure 3. Treatment of a mouse bearing an intracranial GBM tumor of 1.5 mm3, which receives at the
center of its tumor 500–700 µg of M-PLL, followed by 27 applications of an alternating magnetic field
of 27 mT and 200 kHz, each session lasting for 30 min, and resulting in moderate temperature increase
of 0 to 18 ◦C. The decrease of tumor volume down to 0 mm3 10 days following the beginning of the
treatment as well as the absence of tumor in histological analysis of treated tumor brain slides collected
75 days and 125 days following the beginning of the treatments reveal the full tumor disappearance
induced by the treatment. “reproduced with permission in a slightly different format from Biomaterials,
V. 262, P. 259-272 (2017)”.
 
Figure 4. Schematic diagram presenting the possible mechanism of actions associated with anti-tumor
activity, i.e.,: (i) localized heat produced at magnetosome location, either inside or outside cells
depending on whether magnetosomes internalize in tumor cells or remain localized outside these
cells, (ii) an apoptotic mechanism as highlighted when magnetosomes were brought into contact with
U87-Luc cells and exposed to one magnetic session, (iii) mechanism of indirect tumor destruction
involving magnetosomes covering the border of GBM tumor, and (iv) the attraction of immune cells
(PNN) by the magnetosomes since PNN were observed near the magnetosomes in GBM tumors
following a magnetic session although a direct link between the presence of PNN and the anti-tumor
activity was not established.
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Table 2 summarizes the in vitro and in vivo anti-tumor efficacies obtained with the various types
of nanoparticles presented in Table 1.
Table 2. Summarizes the in vitro and in vivo anti-tumor efficacies of the various nanomaterials
presented in Table 1.
Efficacy Results (In Vitro & In Vivo)
of the Different Nanomaterials Presented in Table 1
References
cytotoxicity of NiO NP against HepG2 cancer cells (IC50 = 38 µg/mL) [41], Abbasi 2019
Cytoxicity of Pt NP against MCF-7, HCT-116, HepG-2 cells
(90 < IC50 < 290 µg/mL)
[42], Al-Radad i2019
Cytotoxicity of Pd NP towards A549 lung cancer cells
No cytoxicity towards healthy peripheral lymphocytes
[43], Anand 2016
Pd NP have larger cytotoxicity toward human leukemia (MOLT-4) cells
(IC50 = 0.006 µM) than tea extract (IC50 = 0.9 µM), doxorubicin (IC50 = 2 µM),
or cisplatin (IC50 = 0.013 µM).
NP relatively not cytotoxic towards healthy human fibroblast (HDF-a) cells.
Cytotoxicity due to apoptosis/G2/M cell-cycle arrest
NP have anti-oxydant activity
[44], Azizi 2017
Au NP anticancer activity against HeLa cells
(through apoptosis)
[45], Baharara 2016
Cytotoxicity of ZnO NP towards Hep-G2 cells
(ROS induce damage to DNA of the cells)
[46], Chung 2015
Cu NP are cytotoxic towards MCF-7 breast cancer cells [47], Chung 2017
Te NW (concentration between 5 and 100 µg/mL) improves healthy cell
proliferation/decreases cancer cell growth.
Higher efficacy compared with chemical Te NW.
[48], Crua 2019
Se NP cytotoxic towards HepG2 cells (IC50 = 19 µg/mL)
NP produce ROS
Cellular death through apoptosis
[49], Cui 2018
Cytotoxicity towards MCF-7 breast cancer cells of Ag NP (10 µg/mL) and PDT
(0.5 mJ/cm2)
Due to mitochondrial damage and intracellular ROS production
[50], Erdogan 2019
No CeO2 NP cytotoxicitys on periodental fibroblast cells. [51], Kargar 2015
Rosemary-FeNPs more cytotoxic towards 4T1
and C26 cancer cells than free Rosemary extract
[52], Farschchi 2018
Injection of magnetosomes in glioblastoma followed by several AMF
applications leads to full tumor disappearance
[53], Alphandéry 2017
Magnetosome cytotoxicity towards GBM RG-2 and GL-261 cells under the
application of an AMF of 200 kHz and 40 mT.
[54], Hamdous 2017, 63,
Mandawala 2017
Au NP cytotoxic towards epidermoid carcinoma A431 cells upon laser
irradiation laser at 800 nm (6 W/cm2).
[55], Fazal 2014
Tb2O3 NP cytotoxic towards MG-63 and Saos-2 osteosarcoma cancer cells
(IC50 = 0.102 µg/mL)
Tb203 NP not cytotoxic towards primary osteoblasts up
to 0.373 µg/mL.
[56], Iram 2016
Cytotoxicity of MgO NP towards A-549 human lung cancer cells
(IC50 = 100 µg ml
−1 after 24 h incubation)
Less cytotoxicity of MgO NP twoards healthy vero cells (IC50 = 140 µg/mL)
[57], Majeed 2018
BaCO3 NP cytotoxic towards cervical carcinoma cells [58], Nagajyothi 2016
Possibility to add Curcumin at the surface of bismuth sulfide NP and to induce
cytotoxicity towards HT-29 cells by release of CUR.
[59], Nosrati 2019
Th NP cytotoxic towards A 375 melanoma cells. [60], Pol 2018
CdS QD cytotoxic towards A549 lung cancer cells. [61], Shivaji 2018
CoPt have better biocompatibility/lower toxicity than previously reported Co
NP, Co@Au NP, and CoPt NP.→ due to good biocompatibility/anti-oxidation
potential of polyphenols that prevent cobalt release.
[62], Song 2016
MnO2 NP cytotoxic towards 4T1 breast cancer cells [63], Chen 2016
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7. Conclusions
The development of metallic nanoparticles for cancer treatment is rapidly expanding. This is
due to the wide range of mechanisms of action that such a system can trigger, which depends on the
type of metallic NP used. It includes controlled chemotherapeutic drug delivery, localized heating,
and amplification of radiation. Most efforts in this field have focused on chemical synthesis to obtain
metallic NP. However, such synthesis suffers from a number of drawbacks, notably the use of toxic
products that should be avoided for medical applications. This is the reason why it has recently
been suggested to follow natural synthesis methods, using plant extracts, fungus, yeast, or bacteria,
to produce metallic NP. Such production usually relies on the reduction of metal ions by biological
material, which results in the crystallization of metallic ions into metallic NP. The anti-tumor activity
of most metallic NP has been demonstrated in vitro, where some of the underlying mechanisms have
been described as involving anti-angiogenesis or tumor cell apoptosis, DNA damage, or membrane
disruption. Following a specific purification method that enables the removal of endotoxins and
immunogenic biologic material from nanoparticles, metallic NP, called magnetosomes, which are iron
oxide nanoparticles that are synthesized by magnetotactic bacteria, have been administered inside
glioblastoma tumors grown inside mouse brains, and further excited by several applications of an
alternating magnetic field, resulting in several heating sessions that led to full tumor disappearance.
Therefore, it has been demonstrated that natural metallic nanoparticles have the potential to destroy
tumors pre-clinically. The next step will consist in assessing the efficacy and safety of these natural
metallic NP clinically.
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MS Magnetic session, time during which an AMF is applied on NP
NP Nanoparticles
M-PLL Iron oxide magnetosome minerals coated with poly-L-lysine
NP Nanoparticles
NP backbone Nanoparticle without any drug attached to it
GBM Glioblastoma multiform
PNN Poly nuclear neutrophils
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